Who owns AZIYO BIOLOGICS INC?
- Ticker: ELUT
- CUSIP Number: 05479k106
Tip: Access positions for across all investors
Analyze quarterly positions in Aziyo Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aziyo Biologics stock
Who bought or sold AZIYO BIOLOGICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.7M | $5.2M | 0% | Mar 2024 |
|
| Alyeska Investment Group | 893k | $2.8M | 0% | Mar 2024 |
|
| Perkins Capital Management | 798k | $2.5M | 2% | Mar 2024 |
|
| AIGH Capital Management | 437k | $1.4M | -74% | Mar 2024 |
|
| Vanguard Group | 416k | $1.3M | 41% | Mar 2024 |
|
| Geode Capital Management | 118k | $373k | 70% | Mar 2024 |
|
| Bank of America Corporation | 24k | $74k | 471580% | Mar 2024 |
|
| Millennium Management | 20k | $61k | -8% | Mar 2024 |
|
| BlackRock | 15k | $48k | 7% | Mar 2024 |
|
| Verdence Capital Advisors | 14k | $45k | 0% | Mar 2024 |
|
| Northern Trust | 14k | $44k | 100% | Mar 2024 |
|
| Tower Research Capital | 5.3k | $17k | 212% | Mar 2024 |
|
| Us Bancorp | 625.00 | $2.0k | 0% | Mar 2024 |
|
| UBS Group | 500.00 | $1.6k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 239.00 | $999.999900 | 117% | Mar 2024 |
|
| Wells Fargo & Company | 112.00 | $353.001600 | 2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 24.00 | $76.000800 | 85% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $3.000000 | 0% | Mar 2024 |
|
Who sold out of Aziyo Biologics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Worth Venture Partners | Dec 2023 | 479k | $1.0M |
| Indie Asset Partners | Dec 2023 | 30k | $65k |
| Prosight Management | Sep 2023 | 26k | $37k |
| Virtu Financial | Dec 2023 | 11k | $24k |